Biotech

All Articles

ArsenalBio elevates $325M, turns out of former lead asset

.Toolbox Biosciences is proceeding up. The cell therapy company has added on $325 thousand in ammuni...

Lilly- supported fat loss biotech data IPO

.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has actually fi...

Aelis' cannabis use medicine fails stage 2b, driving Indivior to review $100M option

.Aelis Farma's hopes of getting an easy, positive choice on a $100 thousand option remittance have a...

ProKidney standstills phase 3 trial certainly not required for cell therapy confirmation

.ProKidney has actually ceased one of a set of phase 3 trials for its tissue treatment for kidney di...

Vaxcyte climbs on 'sensational' 31-valent PCV win against Pfizer

.Vaxcyte unveiled what analysts called "impressive" period 1/2 records for its 31-valent pneumococca...

Recursion's human brain condition trial presents little evidence of efficiency

.Recursion has actually stumbled through a very early exam of its tech-enabled technique to medicati...

Acepodia, Pfizer click on all together for chemistry-based cell therapy

.Call it a situation of excellent chemical make up: Acepodia, a biotech based upon Nobel Prize-winni...

Praxis epilepsy medicine lowers seizures in stage 2 trial

.Praxis Accuracy Medicines has actually scored yet another midphase win in epilepsy this year, along...

Three directors surrender as Dyne posts mixed data for DMD applicant

.After getting away a scientific grip several years back, Dyne Therapeutics has actually exposed bra...

Arrowhead fires off phase 3 data in rare metabolic disease ahead of market encounter Ionis

.Arrowhead Pharmaceuticals has presented its own give ahead of a potential showdown along with Ionis...